Release Summary

Inotek Pharmaceuticals today announced the presentation of preclinical data of trabodenoson at the Association for Research in Vision and Ophthalmology (ARVO) 2017 Annual Meeting in Baltimore, MD.

Inotek Pharmaceuticals Corporation